Study Complete
Sponsor ID
20030160
Trial of Extended Treatment with Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects with Idiopathic Parkinson's Disease who Have Completed a Previous Trial of Liatermin
Study Details
The purpose of this study is to determine long-term efficacy of
continuous IPu liatermin infusion administered with concomitant standard
anti-Parkinsonian therapy.
Protocol Summary
Primary Outcome Measures
Percent change in UPDRS
Timeframe: 24 months
Secondary Outcome Measures
Incidence of treatment emergent and device related adverse events
Timeframe: 24 months
Locations
No locations found.